Location History:
- Medford, MA (US) (2016 - 2023)
- Boston, MA (US) (2024)
Company Filing History:
Years Active: 2016-2025
Title: Innovator Profile: Benjamin Kleinstiver
Introduction
Benjamin Kleinstiver, based in Medford, MA, is a distinguished inventor known for his significant contributions to the field of genomic engineering. With an impressive portfolio of 25 patents, he has made remarkable strides in advancing biotechnology and gene editing technologies. His innovative work has garnered attention and recognition in the scientific community, positioning him as a leading figure in genetic research.
Latest Patents
Among his latest patents, Kleinstiver has developed pioneering technologies such as "Engineered CRISPR-Cas9 nucleases with altered PAM specificity" and "Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1." These patents focus on enhancing the specificity of CRISPR-Cas9 nucleases for genomic and epigenomic engineering and enabling drug-inducible and multiplexable gene regulation. His work is expected to have far-reaching implications in the field of genetic engineering and medicine.
Career Highlights
Kleinstiver is currently affiliated with the General Hospital Corporation, where he collaborates with other leading scientists to push the boundaries of genetic research. His career is marked by a commitment to innovation, leading him to develop technologies that improve gene editing precision and versatility. His contributions in this field have not only expanded the scientific toolkit available for researchers but also opened new pathways for therapeutic applications.
Collaborations
Throughout his career, Benjamin Kleinstiver has collaborated with notable scientists, including J Keith Joung and Vikram Pattanayak. These collaborations have fueled groundbreaking research and have played a critical role in the development of advanced gene editing techniques that are shaping the future of molecular biology and medicine. Together, they continue to explore the possibilities of CRISPR technology to revolutionize genome targeting and gene regulation.
Conclusion
Benjamin Kleinstiver is an emerging leader in the field of biotechnology, with a robust patent portfolio that reflects his commitment to innovation and excellence. With ongoing collaborations and groundbreaking research, he is poised to contribute significantly to the advancement of genetic engineering, making profound impacts on health and medicine for years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.